Pharmacy Management System Market (BY Solution Type: Pharmacy Inventory Management System, Pharmacy Data Management System, Pharmacy Compounding Software System, Pharmacy Benefits Management System, Pharmacy Revenue Cycle Management System, Others; By Component: Software, Hardware, Services; By Deployment Mode: Cloud/Web-Based, On-Premise; By End-User: Inpatient Pharmacies, Outpatient Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global pharmacy management system market size was estimated at USD 23.69 billion in 2022 and is expected to hit around USD 57.91 billion by 2032 with a registered CAGR of 9.4% from 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
An essential tool that offers extremely user-friendly and effective organization is a pharmaceutical management solution. These systems aid pharmacists in handling challenging duties like inventory control, medication dispensing, and sales operations. The use of a worldwide pharmacy management system enables pharmacists to provide expert treatment depending on patients' needs. The expansion of pharmacists, the medical IT sector, and improvements in the healthcare system are all contributing factors to the industry growth for pharmacy management system. The procedure in the medicinal industry has grown during the last several years. As a result, the advantages that medications provide to users are very advantageous.
The pressure of handling a rising number of treatments is being placed on pharmacies, which will encourage the use of involuntary explanations to manage the pharmaceutical industry. Small, intermediate, and big pharmacies can all benefit from the autonomous computer solutions provided by pharmacy management system. Governing and agreement data, stock restraint organization record control, and administration performance represent the majority of solutions. By mechanizing reorganization, increasing efficiency, improving finish date chasing, and using progressive rulers to fulfill pharmaceutical needs, the system for pharmacy management also reduces the cost of inventory.
The expansion of the medication management equipment market is being driven by an increase in the number of major pharmaceutical companies using it for better administration in pharmacies. As a consequence, the market players have created a large number of apps, greatly expanding the IT sector. The size of the market for pharmaceutical management systems is growing as a result. To enhance health services, several different solutions have been proposed. Organizations can run their businesses more successfully by utilizing the pharmacy management program. The system aids in the day-to-day operation of the company.
An essential instrument with strong, user-friendly pharmaceutical management systems is a pharmacy management solution. The pharmacist management system helps pharmacists navigate the complexity of managing drug stocks, point-of-sale operations, and medication delivery. Additionally, it helps handle, track, and dispense prescribed medications with greater accuracy, security, and efficiency. The development of healthcare IT is credited with the rise of the medication management equipment market, and over time, it is anticipated that the expansion of chemists everywhere in the world will further increase market development. But in the upcoming years, the market's expansion is probably going to be negatively impacted by the shortcomings of pharmacy management solutions.
Medication that is in the inventory stage till it expires or slow-moving inventory can wind up costing significantly more than the retail value. Major pharmacies employ software supported by medication management systems to maintain drug inventory at current levels to avoid such situations. The pharmacy management system gets significant openness with the exchange by integrating analytical tools. A pharmacy management system's adoption also increases visibility and offers careful monitoring of inventory purchase and administration. These programs assist in increasing inventory turns by up to 35% and reducing losses from unserviceable returns by up to 25%.
Report Coverage | Details |
Market Size in 2023 |
USD 25.8 Billion |
Market Size by 2032 |
USD 57.91 Billion |
Growth Rate from 2023 to 2032 | CAGR of 9.4% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | Solution Type, Component, Deployment Modem, End-User, and Geography |
Companies Mentioned | ACG Infotech Ltd, Allscripts Healthcare Solution Inc., Alphabet Inc., Arterys Inc., Becton Dickinson and Co., Cerner Corporation (US), Clanwilliam Health (Ireland), Datascan (DCS Pharmacy Inc.), Dickinson and Company (CareFusion), Epicor Software Corporation, General Electric Company, GlobeMed Group (Lebanon), Health Business Systems (US), Idhasoft Ltd, Intel Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Liberty Software (US), LS Retail (Iceland), McKesson Corporation, MedHOK (US), Microsoft, Mobile MedSoft (US), Nuance Communications, Inc., NVIDIA CORPORATION, Octal IT Solution LLP (US), Omnicell Inc., QuadraMed Affinity Corporation, Safe care Technology (UAE), ScriptPro (US), Siemens Healthineers AG, Talyst, LLC. |
Key Market Drivers:
Adoption of automated methods in the operation of pharmacies globally
Electronic prescription implementation
Key Market Challenges:
Key Market Opportunities:
A barcode digital scanner, an automated inventory procedure, accounting, warehousing, restocking, and other features are all included in the pharmacy inventory-management system. The customer retention rates, reaction times, spending patterns, and prescription waste rates are all addressed by the pharmacy information management system.
The findings of the numerous clinical trials were produced with cost-effective designs and strategies thanks to the pharmacy compounding software system. Insurance verification, prior authorization, claims processing, mitigation techniques, and many other things are handled by the pharmaceutical revenue cycle administration system.
Programs for hospital security and protection are included in the software. Computers, video conferencing equipment, and high-tech mobile phones are examples of hardware. Services are provided to provide support and results. An internal server is unnecessary with cloud-based systems. Computing experts from the company are used on-site. In 2022, the cloud-based service market was dominant and held a 57.8% revenue share.
Demand for available commercial cloud services is most likely to be significantly influenced by the ease with which information may be accessed in remote areas to use such solutions. Additionally, the market is projected to grow in the next years due to the focus on client data privacy and the development of regulations related to it. Due to several security flaws in web-based as well as on deployment, cloud-based technology deployment is getting a lot of popularity. Providers of cloud services do provide services that address different threats and protect protection against information loss and theft. As a result, this segment of the market accounts for a sizeable portion of the market. The market for medication management systems has the second-largest share of web-based options in 2022. This can be linked to doctors increasingly favoring web-based solutions over cloud-based ones because they are more affordable.
The largest market share for pharmacy management system is held by inpatient pharmacies. The sector with the fastest growth is an outpatient pharmacy.
North America has the largest industry shares for pharmaceutical management systems due to the presence of key players there. Europe maintains the second-highest market share due to pharmacies in this region using IT solutions.
Over the forecast period, Asia Pacific is expected to have the greatest CAGR of any region. This region will expand significantly as agreements and partnerships grow. Africa and the Middle East have always had the lowermost markets because of their limited access to healthcare.
Segments Covered in the Report:
By Solution Type
By Component
By Deployment Mode
By End-User
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmacy Management System Market
5.1. COVID-19 Landscape: Pharmacy Management System Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmacy Management System Market, By Solution Type
8.1. Pharmacy Management System Market, by Solution Type, 2023-2032
8.1.1. Pharmacy Inventory Management System
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Pharmacy Data Management System
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Pharmacy Compounding Software System
8.1.3.1. Market Revenue and Forecast (2021-2032)
8.1.4. Pharmacy Benefits Management System
8.1.4.1. Market Revenue and Forecast (2021-2032)
8.1.5. Pharmacy Revenue Cycle Management System
8.1.5.1. Market Revenue and Forecast (2021-2032)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Pharmacy Management System Market, By Component
9.1. Pharmacy Management System Market, by Component, 2023-2032
9.1.1. Software
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Hardware
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Services
9.1.3.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Pharmacy Management System Market, By Deployment Mode
10.1. Pharmacy Management System Market, by Deployment Mode, 2023-2032
10.1.1. Cloud/Web-Based
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. On-Premise
10.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 11. Global Pharmacy Management System Market, By End-User
11.1. Pharmacy Management System Market, by End-User, 2023-2032
11.1.1. Inpatient Pharmacies
11.1.1.1. Market Revenue and Forecast (2021-2032)
11.1.2. Outpatient Pharmacies
11.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 12. Global Pharmacy Management System Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.1.2. Market Revenue and Forecast, by Component (2021-2032)
12.1.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.1.4. Market Revenue and Forecast, by End-User (2021-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.1.5.2. Market Revenue and Forecast, by Component (2021-2032)
12.1.5.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.1.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.1.6.2. Market Revenue and Forecast, by Component (2021-2032)
12.1.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.1.6.4. Market Revenue and Forecast, by End-User (2021-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.2.2. Market Revenue and Forecast, by Component (2021-2032)
12.2.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.2.4. Market Revenue and Forecast, by End-User (2021-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.2.5.2. Market Revenue and Forecast, by Component (2021-2032)
12.2.5.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.2.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.2.6.2. Market Revenue and Forecast, by Component (2021-2032)
12.2.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.2.6.4. Market Revenue and Forecast, by End-User (2021-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.2.7.2. Market Revenue and Forecast, by Component (2021-2032)
12.2.7.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.2.7.4. Market Revenue and Forecast, by End-User (2021-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.2.8.2. Market Revenue and Forecast, by Component (2021-2032)
12.2.8.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.2.8.4. Market Revenue and Forecast, by End-User (2021-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.3.2. Market Revenue and Forecast, by Component (2021-2032)
12.3.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.3.4. Market Revenue and Forecast, by End-User (2021-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.3.5.2. Market Revenue and Forecast, by Component (2021-2032)
12.3.5.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.3.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.3.6.2. Market Revenue and Forecast, by Component (2021-2032)
12.3.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.3.6.4. Market Revenue and Forecast, by End-User (2021-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.3.7.2. Market Revenue and Forecast, by Component (2021-2032)
12.3.7.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.3.7.4. Market Revenue and Forecast, by End-User (2021-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.3.8.2. Market Revenue and Forecast, by Component (2021-2032)
12.3.8.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.3.8.4. Market Revenue and Forecast, by End-User (2021-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.4.2. Market Revenue and Forecast, by Component (2021-2032)
12.4.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.4.4. Market Revenue and Forecast, by End-User (2021-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.4.5.2. Market Revenue and Forecast, by Component (2021-2032)
12.4.5.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.4.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.4.6.2. Market Revenue and Forecast, by Component (2021-2032)
12.4.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.4.6.4. Market Revenue and Forecast, by End-User (2021-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.4.7.2. Market Revenue and Forecast, by Component (2021-2032)
12.4.7.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.4.7.4. Market Revenue and Forecast, by End-User (2021-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.4.8.2. Market Revenue and Forecast, by Component (2021-2032)
12.4.8.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.4.8.4. Market Revenue and Forecast, by End-User (2021-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.5.2. Market Revenue and Forecast, by Component (2021-2032)
12.5.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.5.5.2. Market Revenue and Forecast, by Component (2021-2032)
12.5.5.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.5.5.4. Market Revenue and Forecast, by End-User (2021-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Solution Type (2021-2032)
12.5.6.2. Market Revenue and Forecast, by Component (2021-2032)
12.5.6.3. Market Revenue and Forecast, by Deployment Mode (2021-2032)
12.5.6.4. Market Revenue and Forecast, by End-User (2021-2032)
Chapter 13. Company Profiles
13.1. ACG Infotech Ltd
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Allscripts Healthcare Solution Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Alphabet Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Arterys Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Becton Dickinson and Co.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Cerner Corporation (US)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Clanwilliam Health (Ireland)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Datascan (DCS Pharmacy Inc.)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Dickinson and Company (CareFusion)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Epicor Software Corporation
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client